A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

NCT05827016 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1216

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Iberdomide
DRUG: Lenalidomide

Sponsor

Bristol-Myers Squibb